Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6 Pt 1
|
pubmed:dateCreated |
1989-7-28
|
pubmed:abstractText |
Long-term effects of a novel angiotensin converting enzyme (ACE) inhibitor, CS-622, on Ca2+-dependent tone in aortic smooth muscles of spontaneously hypertensive rats (SHR) were examined. CS-622 (3 or 10 mg/kg/day), when orally administered to SHR for 21 weeks, exhibited a dose-dependent antihypertensive action. In Krebs-Henseleit solution, removal of Ca2+ caused much greater relaxation in aortas excised from control SHR than those from SHR treated with CS-622. Restoration of Ca2+ from zero to 2.5 mM elicited a marked contraction in aortas from control SHR but only a small contraction in aortas from both CS-622-treated SHR and normotensive Wistar-Kyoto rats. These findings suggested that myogenic tone that resulted from increased Ca2+ permeability in aortas of SHR was suppressed by long-term treatment with CS-622. The aortic tone from the individual rats correlated well with systolic blood pressure in both CS-622-treated and control SHR. The exaggerated myogenic tone in aortas of SHR was attenuated in the medium containing nicardipine but was not altered in the presence of CS-622 diacid (active form of CS-622) at a concentration high enough to fully inhibit aortic ACE. The myogenic tone in normal Ca2+ concentration was not decreased in aortas excised from SHR treated with hydralazine (5 mg/kg/day) for 21 weeks. We conclude that after prolonged administration CS-622 reduced the high vascular tension resulting from increased Ca2+ permeability of vascular smooth muscle membrane in SHR and that the restoration of normal Ca2+ permeability of vascular smooth muscles may underlie long-term antihypertensive action of ACE inhibitors.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin-Converting Enzyme...,
http://linkedlifedata.com/resource/pubmed/chemical/Calcium,
http://linkedlifedata.com/resource/pubmed/chemical/Calcium Channel Blockers,
http://linkedlifedata.com/resource/pubmed/chemical/Nicardipine,
http://linkedlifedata.com/resource/pubmed/chemical/Thiazepines,
http://linkedlifedata.com/resource/pubmed/chemical/temocapril hydrochloride
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0194-911X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
582-8
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:2737707-Administration, Oral,
pubmed-meshheading:2737707-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:2737707-Animals,
pubmed-meshheading:2737707-Aorta,
pubmed-meshheading:2737707-Blood Pressure,
pubmed-meshheading:2737707-Calcium,
pubmed-meshheading:2737707-Calcium Channel Blockers,
pubmed-meshheading:2737707-Dose-Response Relationship, Drug,
pubmed-meshheading:2737707-Hypertension,
pubmed-meshheading:2737707-Male,
pubmed-meshheading:2737707-Nicardipine,
pubmed-meshheading:2737707-Rats,
pubmed-meshheading:2737707-Rats, Inbred SHR,
pubmed-meshheading:2737707-Rats, Inbred WKY,
pubmed-meshheading:2737707-Thiazepines,
pubmed-meshheading:2737707-Time Factors
|
pubmed:year |
1989
|
pubmed:articleTitle |
Chronic inhibition of angiotensin converting enzyme decreases Ca2+-dependent tone of aorta in hypertensive rats.
|
pubmed:affiliation |
Cardiovascular Division, Sankyo Co., Ltd., Tokyo, Japan.
|
pubmed:publicationType |
Journal Article
|